ESSA Pharma Inc
(TSX Venture Exchange : EPIX)

( )
EPIX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
0.04%145.440.6%$1129.68m
MRKMerck & Co., Inc.
1.85%78.130.6%$1025.05m
PFEPfizer Inc.
-0.29%43.800.9%$994.23m
ABBVAbbVie, Inc.
0.02%86.962.2%$612.47m
LLYEli Lilly and Company
-0.80%112.671.0%$518.45m
BMYBristol-Myers Squibb Company
0.00%53.081.4%$462.56m
NVSNovartis AG Sponsored ADR
0.28%87.300.2%$236.24m
AZNAstraZeneca PLC Sponsored ADR
2.38%39.091.3%$206.37m
GSKGlaxoSmithKline plc Sponsored ADR
0.89%37.610.2%$137.13m
NVONovo Nordisk A/S Sponsored ADR Class B
1.06%45.860.1%$63.34m
SNYSanofi Sponsored ADR
1.38%44.070.2%$43.09m
LCILannett Company, Inc.
-1.65%5.3737.0%$12.19m

Company Profile

ESSA Pharma, Inc. is a pharmaceutical company. It engages in the development of small molecule drugs for the treatment of prostate cancer. The company was founded by Marianne D. Sadar and Raymond J. Andersen on January 6, 2009 and is headquartered in Vancouver, Canada.